Sabatini Brent bought VIR
February 22, 2026 · Form 4 insider transaction
Sabatini Brent bought 50,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderSabatini Brent
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2026
Filing dateFebruary 24, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.